Zobrazeno 1 - 10
of 88
pro vyhledávání: ''
Autor:
Weili Qi, Chuan Li, Wei Peng, Junlong Dai, Shun Ran, Junyi Shen, Yu Zhang, Shusheng Leng, Tian-Fu Wen, Youwei Wu, Xiaoyun Zhang, Fengwei Gao
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8421-8431 (2021)
Cancer Medicine
Cancer Medicine
Background Antiviral therapy should reduce the recurrence of hepatitis B virus‐related hepatocellular carcinoma (HBV‐related HCC) after surgical resection. However, there is little research on whether various antiviral drugs have different progno
Autor:
Li Pang, Zhiqiang Guo
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8558-8569 (2021)
Cancer Medicine
Cancer Medicine
Background There is currently no recognized first‐line treatment strategy for ovarian neuroendocrine tumors (NETs). Furthermore, because of the low incidence of ovarian NETs, no studies have reported prognostic statistics derived from large samples
Autor:
De Shen Wang, Long Bai, Han Zhou, Wan-Lan Huang, Ze-Yu Lin, Qin Chen, Yun-Le Wan, Yun-Xin Lu, Qi Meng, Chun-Ping Lin, Zhizhong Pan
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8005-8019 (2021)
Cancer Medicine
Cancer Medicine
Background The prognostic value of lactate dehydrogenase (LDH) in colorectal cancer patients has remained inconsistent between nonmetastatic and metastatic settings. So far, very few studies have included LDH in the prognostic analysis of curative‐
Autor:
Wen-Ting Tang, Xin-Hua Yang, Fang Wang, Wen-Jian Cen, Ren-Jing Zhang, Jiao-Jiao Yang, Xiao-Meng Ji, Jian Yong Shao, Ya-Kang Long, Ziming Du, Li-Yue Sun
Publikováno v:
Cancer Medicine, Vol 10, Iss 19, Pp 6610-6617 (2021)
Cancer Medicine
Cancer Medicine
Background This study aimed to explore the prognostic value of tumor mutational burden (TMB) combined with smoking status in advanced non‐small cell lung cancer (NSCLC) patients who received immune checkpoint inhibitor therapy (anti PD‐1/PD‐L1
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6291-6303 (2021)
Cancer Medicine
Cancer Medicine
Background Many tools have been developed to predict the efficacy of immunotherapy, such as lung immune prognostic index (LIPI), EPSILoN [Eastern Cooperative Oncology Group performance status (ECOG PS), smoking, liver metastases, lactate dehydrogenas
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Purpose To discuss whether the dome or anterior wall of bladder adenocarcinoma (BAC) should be classified into urachal carcinoma (UrC) and the relationship of primary tumor location (PTL) as well as treatment with survival. Methods Surveillance, Epid
Autor:
Wenping Lin, Lianghe Lu, Wei Wei, Rong Ping Guo, Zhixing Guo, Shao-Hua Li, Zhi-Yuan Chen, Jie Mei
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5466-5474 (2021)
Cancer Medicine
Cancer Medicine
Background The predictive value of vessels encapsulating tumor clusters (VETC) in recurrent early‐stage hepatocellular carcinoma (HCC) remains unclear. Therefore, the aim of the present study was to investigate the prognostic significance of VETC i
Autor:
Oki Nakano, Kazunao Hayashi, Junji Kohisa, Junji Yokoyama, Takamasa Kobayashi, Satoshi Ikarashi, Hirokazu Kawai, Shuji Terai
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4291-4301 (2021)
Cancer Medicine
Cancer Medicine
Background Involuntary weight loss related to cachexia is common in patients with advanced cancer, but the association between body composition changes and survival is still unclear in pancreatic cancer. Methods We retrospectively reviewed the clinic
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 14, Pp 4697-4709 (2021)
Cancer Medicine, Vol 10, Iss 14, Pp 4697-4709 (2021)
Background Epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) has been considered as an effective treatment in epidermal growth factor receptor‐mutant (EGFR‐mutant) advanced non‐small cell lung cancer (NSCLC). However, mo
Autor:
Guilan Xie, Liren Yang, Ruiqi Wang, Mei Chun Chung, Wenfang Yang, Liyan Huang, Li Shang, Cuifang Qi
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 10, Pp 3205-3213 (2021)
Cancer Medicine, Vol 10, Iss 10, Pp 3205-3213 (2021)
Background The incidence of endometrial cancer has tended to increase in recent years. However, competing risk nomogram combining comprehensive factors for endometrial cancer patients treated with hysterectomy is still scarce. Therefore, we aimed to